RR-TB

Clinical trials for RR-TB explained in plain language.

Never miss a new study

Get alerted when new RR-TB trials appear

Sign up with your email to follow new studies for RR-TB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to shorten tough TB treatment

Disease control Not yet recruiting

This study tests whether adding acetohydroxamic acid (AHA) to a short-course drug regimen can safely and effectively treat multidrug-resistant tuberculosis (MDR-TB). About 120 adults with confirmed MDR-TB will receive either AHA or a placebo along with standard short-course antib…

Matched conditions: RR-TB

Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

RR-TB

Get alerted when new RR-TB trials appear

New drug combo aims to shorten tough TB treatment